Skip to content

Evaluation of the efficacy of Cranbery in treatment of Fatty Liver

Evaluation of the efficacy of Cranbery in management of non-alcoholic Fatty Liver Patients

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200725048200N1
Enrollment
94
Registered
2020-08-11
Start date
2020-07-27
Completion date
Unknown
Last updated
2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-alcoholic fatty liver. Fatty (change of) liver, not elsewhere classified

Interventions

Intervention 1: Intervention group: The first intervention group includes patients with grade 1, 2 and 3 liver.Cranberry extract is called Cranberry Shari, which is the brand name.Ingredients of its f

Sponsors

Gastrointestinal and Liver Diseases Research Center, Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients with non-alcoholic fatty liver grade1, 2 and 3 Patients with newly diagnosed fatty liver Candidates for fatty liver treatment

Exclusion criteria

Exclusion criteria: Patient dissatisfaction Rule out the diagnosis of fatty liver Drug intolerance Existence of diabetes, , heart, renal and pulmonary failure, other liver diseases in which fatty liver appears in the picture alcohol consumption antioxidant and vitamins supplements other that vitamin E pregnant and lactating mothers

Design outcomes

Primary

MeasureTime frame
Determination of lipid profile level before and after cranberry and placebo use. Timepoint: Study time and 6 months after taking cranberry extract and placebo. Method of measurement: Perform blood tests.;Determination of serum insulin and fasting glucose levels before and after cranberry and placebo. Timepoint: Study time and 6 months after taking cranberry extract and placebo. Method of measurement: Perform blood tests.;Determination of Ultrasound grade before and after cranberry and placebo. Timepoint: Study time and 6 months after taking cranberry extract and placebo. Method of measurement: Ultrasound device.;Determination of serum levels of liver enzymes before and after cranberry and placebo. Timepoint: Study time and 6 months after taking cranberry extract and placebo. Method of measurement: Perform blood tests.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKourosh Masnadi shirazi nezhad

Tabriz University of Medical Sciences

kurmas23@yahoo.com+98 41 3334 7054

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 14, 2026